These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34585430)

  • 1. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy.
    Taghizade S; Chattu VK; Jaafaripooyan E; Kevany S
    Front Public Health; 2021; 9():655021. PubMed ID: 34322467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine apartheid: This is not the way to end the pandemic.
    Lanziotti VS; Bulut Y; Buonsenso D; Gonzalez-Dambrauskas S
    J Paediatr Child Health; 2022 Feb; 58(2):228-231. PubMed ID: 34674333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving Global Vaccine Equity: The Case for an International Pandemic Treaty.
    Jecker NS
    Yale J Biol Med; 2022 Jun; 95(2):271-280. PubMed ID: 35782474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating inequities: a roadmap out of the pandemic.
    Ismail SJ; Tunis MC; Zhao L; Quach C
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33479019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing 'equity' in COVID-19 vaccine distribution through Global Health Diplomacy.
    Singh B; Chattu VK
    Health Promot Perspect; 2021; 11(3):281-287. PubMed ID: 34660222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine nationalism will persist: global public goods need effective engagement of global citizens.
    Peacock SJ
    Global Health; 2022 Feb; 18(1):14. PubMed ID: 35151344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Global Health Security: Overview of the Global Health Security Alliance, COVID-19 Response, African Countries' Approaches, and Ethics.
    Yimer B; Ashebir W; Wolde A; Teshome M
    Disaster Med Public Health Prep; 2022 Apr; 16(2):426-430. PubMed ID: 33004106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priorities for global access to life-saving interventions during public health emergencies: Crisis nationalism, solidarity or charity?
    Syntia Munung N; Ujewe SJ; Afolabi MO
    Glob Public Health; 2022; 17(9):1785-1794. PubMed ID: 34555300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.